China Biotech Services Holdings Limited (8037.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap770.83M
Enterprise Value1.15B
P/E Ratio-11.47
PEG Ratio-0.11
Price/Sales Ratio4.33
Price/Book Ratio1.83
Enterprise/Revenue8.8
Enterprise/EBITDA-13.91

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.38
Operating Margin-1.1
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.16

Income Statement

Revenue73.5M
Revenue/Share0.09
Gross Profit7.73M
EBITDA-59.65M
Net Income-68.78M
Diluted EPS-0.07

Balance Sheet

Total Cash53.84M
Total Cash/Share0.06
Total Debt461.88M
Total Debt/Equity2.13
Current Ratio0.99
Book Value Per Share0.19

Price History

52-Week Change-55.49
52-Week High1.04
52-Week Low0.3
Moving Average 50 Days0.53
Moving Average 200 Days0.62

Statistics

Average Volume272,407
Shares Outstanding975.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:2
Last Split DateFebruary 23, 2016
AD